Molecular genetic and endocrine predictors of menstrual cycle regulation in patients with polycystic ovary syndrome undergoing metformin treatment


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Objective: To identify clinical, laboratory and molecular genetic predictors of menstrual circle regulation in patients with polycystic ovary syndrome (PCOS) undergoing metformin treatment. Materials and methods: The study included 143 women with PCOS (mean age is 26.4±4.6 years, mean body mass index is 23.8 (4.8) kg/m2). The assessment of androgen prof ile and levels of AMH, LH, FSH was performed before and 6 months after the treatment. Also, 2-hour oral glucose tolerance test with insulin level examination and dual-energy X-ray absorptiometry were done. Single-nucleotide polymorphisms (SNPs) were genotyped using polymerase chain reaction and next generation sequencing for 45 loci. All patients were administered metformin (Glucophage Long) 1500 mg/day with dose titration for 6 months. Depending on the response to the therapy, the patients were divided into two groups: group 1 included 70 (53.1%) patients whose menstrual cycle was regulated, group 2 consisted of 48 (36.3%) patients without any effect of therapy; 14 (10.6%) patients with partial response to therapy were not included in the analysis of predicting the effectiveness of the treatment. Statistical analysis was carried out with SPSS Statistics 21. Parametric tests were used for the analysis of clinical data; odds ratio was calculated for the analysis of molecular genetic data. Results: The following independent predictors of the effectiveness of metformin therapy in PCOS were revealed: AMH level less than 13.3 ng/ml, total testosterone level less than 1.81 ng/ml, index of adipose tissue distribution A/G less than 0.90, as well as polymorphism of loci in the genes SLCO1B1 (rs4149056), ACE (rs4340), FSHR (rs2349415), OST1 (rs113569197). The model which was developed for predicting menstrual cycle regulation in patients with PCOS undergoing metformin therapy included the baseline level of AMH and rs2349415 SNPs of FSHR gene. Conclusion: The most significant factors determining metformin effectiveness in PCOS patients were AMH level and genotype С/С of FSHR (rs2349415).

Толық мәтін

Рұқсат жабық

Авторлар туралы

Galina Chernukha

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: g_chernukha@oparina4.ru
Dr. Med. Sci., Professor, Chief Researcher, Department of Gynecological Endocrinology

Alina Naidukova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

PhD. Student, Department of Gynecological Endocrinology

Elena Kaprina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: kaprina_elena@mail.ru
PhD. Student, Department of Gynecological Endocrinology

Ekaterina Miroshina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: emiroshina.md@gmail.com
Junior Researcher, Department of Gynecologic Endocrinology

Andrey Donnikov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: a_donnikov@oparina4.ru
M.D., Ph.D., Head of the Laboratory of Molecular Genetic Methods

Әдебиет тізімі

  1. Neven A.C.H., Laven J., Teede H.J., Boyle J.A. A summary on polycystic ovary syndrome: Diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin. Reprod. Med. 2018; 36(1): 5-12. https://dx.doi.org/10.1055/s-0038-1668085.
  2. Cassar S., Misso M.L., Hopkins W.G., Shaw C.S., Teede H.J., Stepto N.K. Insulin resistance in polycystic ovary syndrome: A systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum. Reprod. 2016; 31(11): 2619-31. https://dx.doi.org/10.1093/humrep/dew243.
  3. Kollmann M., laritsch P., Martins W.P., Guenther F., Schneider V., Herzog S.A. et al. Maternal and neonatal outcomes in pregnant women with PCOS: Comparison of different diagnostic definitions. Hum. Reprod. 2015; 30(10): 2396-403. https://dx.doi.org/10.1093/humrep/dev187.
  4. Министерство здравохранения Российской Федерации. Клинические рекомендации. Синдром поликистозных яичников. 2021: 1-54. [Ministry of Health of the Russian Federation. Clinical guidelines. Polycystic Ovarian Syndrome. 2021: 1-54. (in Russian)].
  5. Kai Y., Kawano Y., Yamamoto H., Narahara H. A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells. Reprod. Biol. Endocrinol. 2015; 13: 27. https://dx.doi.org/10.1186/s12958-015-0023-2.
  6. Wierman M.E., Auchus R.J., Haisenleder D.J., Hall J.E., Handelsman D., Hankinson S. et al. Editorial: The new instructions to authors for the reporting of steroid hormone measurements. J. Clin. Endocrinol. Metab. 2014; 99(12): 4375. https://dx.doi.org/10.1210/jc.2014-3424.
  7. Григорян О.Р., Андреева Е.Н., Мельниченко Г.А., Дедов И.И. Влияние метформина на уровень антимюллерова гормона в терапии синдрома поликистозных яичников у женщин с ожирением. Проблемы репродукции. 2013; 1: 39-41. [Grigorian O.R., Andreeva E.N., Melnichenko G.A., Dedov I.I. The influence of metformin on amh level in obese patients with pcos.Russian Journal of Human Reproduction. 2013; 1: 39-41. (in Russian)].
  8. Forslund K., Hildebrand F., Nielsen T., Falony G., Le Chatelier E., Sunagawa S. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015; 528(7581): 262-266. https://dx.doi.org/10.1038/nature15766.
  9. Vallianou N.G., Stratigou T., Tsagarakis S. Metformin and gut microbiota: their interactions and their impact on diabetes. Hormones (Athens). 2019; 18(2): 141-4. https://dx.doi.org/10.1007/s42000-019-00093-w.
  10. Найдукова А.А., Ананьев Е.В., Чернуха Г.Е. Влияние метформина на репродуктивную функцию женщин с различными фенотипами СПКЯ. Акушерство и гинекология. 2017; 10: 55-61. [Naidukova A.A., Ananyev E.V., Chernukha G.E. Effect of metformin on the reproductive function of women with different phenotypes of polycystic ovary syndrome. Obstetrics and Gynecology. 2017; 10: 55-61. (in Russian)]. https://dx.doi.org/10.18565/aig.2017.10.55-61.
  11. Schweighofer N., Lerchbaum E., Trummer O., Schwetz V., Pieber T., Obermayer-Pietsch B. Metformin resistance alleles in polycystic ovary syndrome: Pattern and association with glucose metabolism. Pharmacogenomics. 2014; 15(3): 305-17. https://dx.doi.org/10.2217/pgs.13.223.
  12. Nestler J.E., Jakubovich D.J. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N. Engl. J. Med. 1996; 335(9): 617-23. https://dx.doi.org/10.1056/NEJM199608293350902.
  13. Huhtala M.S., Tertti K., Juhila J., Sorsa T., Ronnemaa T. Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 - secondary analysis of a randomized controlled trial. BMC Pregnancy Childbirth. 2020; 20(1): 401. https://dx.doi.org/10.1186/s12884-020-03077-6.
  14. Shpakov A.O. Improvement effect of Metformin on female and male reproduction in endocrine pathologies and its mechanisms. Pharmaceuticals (Basel). 2021; 14(1): 42. https://dx.doi.org/10.3390/ph14010042.
  15. Attia G.R., Rainey W.E., Carr B.R. Metformin directly inhibits androgen production in human thecal cells. Fertil. Steril. 2001; 76(3): 517-24. https://dx.doi.org/10.1016/s0015-0282(01)01975-6.
  16. JiangZ.Z., HuM.W., MaX.S., SchattenH., FanH.Y., WangZ.B., Sun Q.Y. LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool. Oncotarget. 2016; 7(5): 5738-53. https://dx.doi.org/10.18632/oncotarget.6792.
  17. Roland A.V., Moenter S.M. Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood. Endocrinology. 2011; 152(2): 618-28. https://dx.doi.org/10.1210/en.2010-0823.
  18. Tosca L., Chabrolle C., Uzbekova S., Dupont J. Effects of metformin on bovine granulosa cells steroidogenesis: Possible involvement of adenosine 5' monophosphate-activated protein kinase (AMPK). Biol. Reprod. 2007; 76(3): 368-78. https://dx.doi.org/10.1095/biolreprod.106.055749.
  19. Tosca L., Rame C., Chabrolle C., Tesseraud S., Dupont J. Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells. Reproduction. 2010; 139(2): 409-18. https://dx.doi.org/10.1530/REP-09-0351.
  20. Maciel G.A.R., Soares Jdnior J.M., Alves da Motta E.L., Abi Haidar M., de Lima G.R., Baracat E.C. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertil. Steril. 2004; 81(2): 355-60. https://dx.doi.org/10.1016/j.fertnstert.2003.08.012.
  21. Maciel G.A.R., Hayashida S.A., da Costa L.C., Marcondes J.A., da Fonseca A.M., Soares J.M. Jr, Baracat E.C. Influence of LH and high-density lipoprotein cholesterol (HDL-C) on metformin response in women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011; 157(2): 180-4. https://dx.doi.org/10.1016/j.ejogrb.2011.03.028.
  22. Neagu M., Cristescu C. Anti-Mullerian hormone--a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome. J. Med. Life. 2012; 5(4): 462-4.
  23. Чернуха Г.Е., Байдукова А.А., Каприна Е.К., Донников А.Е. Молекулярногенетические предикторы формирования синдрома поликистозных яичников и его андрогенных фенотипов. Акушерство и гинекология. 2021; 4: 120-7. [Chernukha G.E., Naidukova A.A., Kaprina E.K., Donnikov A.E. Molecular genetic predictors of polycystic ovary syndrome and its androgenic phenotypes. Obstetrics and Gynecology. 2021; 4: 120-7. (in Russian)]. https://dx.doi.org/10.18565/aig.202L4.120-127.
  24. Coviello A.D., Haring R., Wellons M., Vaidya D., Lehtimaki T., Keildson S. et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple loci implicated in sex steroid hormone regulation. PLoS Genet. 2012; 8(7): e1002805. https://dx.doi.org/10.1371/journal.pgen.1002805.
  25. Cintra M.T.R., Balarin M.A.S., Tanaka S.C.S.V., Silva V.I.M.D., Marqui A.B.T., Resende E.A.M.R. et al. Polycystic ovarian syndrome: Rs 1799752 polymorphism of ACE gene. Rev. Assoc. Med. Bras. 2018; 64(11): 1017-22. https://dx.doi.org/10.1590/1806-9282.64.11.1017.
  26. Laven J.S.E. Follicle stimulating hormone receptor (FSHR) polymorphisms and polycystic ovary syndrome (PCOS). Front. Endocrinol. (Lausanne). 2019; 10: 23. https://dx.doi.org/10.3389/fendo.2019.00023
  27. Simoni M., Tempfer C.B., Destenaves B., Fauser B.C. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum. Reprod. Update. 2008; 14(5): 459-84. https://dx.doi.org/10.1093/humupd/dmn024.
  28. Wang D.S., Jonker J.W., Kato Y., Kusuhara H., Schinkel A.H., Sugiyama Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J. Pharmacol. Exp. Ther. 2002; 302(2): 510-5. https://dx.doi.org/10.1124/jpet.102.034140.
  29. Zolk O. Disposition of metformin: Variability due to polymorphisms of organic cation transporters. Ann. Med. 2012; 44(2): 119-29.
  30. Chang H.H., Hsueh Y.S., Cheng Y.W., Ou H.T., Wu M.H. Association between polymorphisms of OCT1 and metabolic response to metformin in women with polycystic ovary syndrome.Int. J. Mol. Sci. 2019; 20(7): 1720. https://dx.doi.org/10.3390/ijms20071720.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2022

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>